Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. MTEM Will Use Platform To Research Canc
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Deal Should Help Gilead “Gly
Start-Up Execs Abide Therapeutics Inc. Gary O’Neill, PhD To: VP, Biology (October) From: VP, & Discovery Site Head, Merck Research Laboratories Phone: 858-427-2590 Akebia Therapeutics Inc.
A look at financing, M&A, and alliance activity January – March 2010 In this issue, we present another installment of our quarterly review of medical device and in vitro diagnostics/research dealmakin